Tenon Medical (TNON)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	9.16 mm	9.16 mm	9.16 mm	9.16 mm	9.16 mm	9.16 mm
Cash burn (monthly)	(no burn)	(no burn)	1.07 mm	1.14 mm	781.00 k	781.58 k
Cash used (since last report)	n/a	n/a	5.43 mm	5.80 mm	3.96 mm	3.96 mm
Cash remaining	n/a	n/a	3.73 mm	3.36 mm	5.21 mm	5.20 mm
Runway (months of cash)	n/a	n/a	3.5	2.9	6.7	6.7

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

TNON institutional ownership history Ownership history

78.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	7	8	-12.5%
Opened positions	5	6	-16.7%
Closed positions	6	11	-45.5%
Increased positions	0	1	EXIT
Reduced positions	1	0	NEW

13F shares	Current	Prev Q	Change
Total value	97.23 mm	429.78 mm	-77.4%
Total shares	2.46 mm	11.22 mm	-78.1%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Ventures AG Zuhlke	2.45 mm	$52.90 mm	0.0%
Spectrum Asset Management	10.03 k	$42.51 mm	NEW
Tower Research Capital	404.00	$1.71 mm	NEW
Clear Street	261.00	$1.00 k	-100.0%
AlphaMark Advisors	50.00	$0.00	NEW
BNP Paribas Arbitrage	25.00	$106.00 k	NEW
C Citigroup	1.00	$4.00 k	NEW
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
TMD Wealth Management	0.00	-5.13 mm	EXIT
Clear Street	261.00	-1.22 mm	-100.0%
CVI	0.00	-999.40 k	EXIT
Warberg Asset Management	0.00	-668.97 k	EXIT
Cable Car Capital	0.00	-508.20 k	EXIT
Armistice Capital	0.00	-178.00 k	EXIT
Citadel Advisors	0.00	-66.02 k	EXIT
Spectrum Asset Management	10.03 k	+10.03 k	NEW
Tower Research Capital	404.00	+404.00	NEW
AlphaMark Advisors	50.00	+50.00	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TNON insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
27 Nov 23	Richard Ginn	Common Stock	Payment of exercise	Dispose F	No	No	2.0001	2,302	4.60 k	70,963
27 Nov 23	Steven M Foster	Common Stock	Payment of exercise	Dispose F	No	No	2.0001	901	1.80 k	8,730
22 Nov 23	Richard Ginn	Common Stock	Conversion	Acquire C	No	No	2.02	7,516	15.18 k	73,265
22 Nov 23	Dick Steven M Van	Common Stock	Conversion	Acquire C	No	No	2.02	1,522	3.07 k	11,565
22 Nov 23	Steven M Foster	Common Stock	Conversion	Acquire C	No	No	2.02	3,624	7.32 k	9,631

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

Tenon Medical Has Received A Decision To Grant European Patent Number EP3372179 Titled "SYSTEM FOR SACRO-ILIAC (JOINT) STABILIZATION"

18 Feb 25

https://register.epo.org/application?number=EP17211157

Press releases

From Benzinga Pro

Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco

9 Jan 25

LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ)